Teva Pharmaceuticals CEO Richard Francis reflects on company performance in 2024, drug pricing, getting more drugs to market and supply shortages of the drug Adderall.
He speaks to “Bloomberg Open Interest” from the JPMorgan Healthcare Conference. (Source: Bloomberg)
Teva CEO on Drug Pricing, Generics, Supply Shortages
Login
0 Comments
Oldest